Sentences with phrase «cancer immunology research»

M.D. Anderson researcher Jim Allison wins Breakthrough Prize for his innovative cancer immunology research.

This year's event raised nearly $ 91,000, with all proceeds going to CRI to support cancer immunology research.

SPRINGFIELD, Mo., and NEW YORK, October 24, 2017 — Fight Colorectal Cancer (Fight CRC) and the Cancer Research Institute (CRI) are proud to announce «A Blueprint to Advance Colorectal Cancer Immunotherapies» will be published in the November 2017 issue of the journal Cancer Immunology Research (published online ahead of print on October 16, 2017).

To view the online manuscript of «A Blueprint to Advance Colorectal Cancer Immunotherapies» published in Cancer Immunology Research, visit http://cancerimmunolres.aacrjournals.org/content/early/2017/10/14/2326-6066.CIR-17-0375.long

Fight Colorectal Cancer, Cancer Research Institute announce Cancer Immunology Research article publication discussing CRC immunotherapy advancement

Christophe Quéva, chief scientific officer, commented «The building of a custom designed R&D facility demonstrates our commitment to our cancer immunology research programs and will enable us to recruit additional qualified scientists needed in both our drug discovery and development.»

As a new collaboration with Cancer Research Institute (CRI), Cancer Immunity will publish its final issue and Cancer Immunology Research will continue to publish cutting - edge research in cancer immunology.

The Center for Cancer Immunology Research (CCIR) addresses immunology - based approaches to the treatment of cancer and has emerged as a one - of - a-kind cancer immunology research program that allows laboratory immunologists to work with clinical oncologists to develop new or improved forms of cancer immunotherapy that activate and instruct our immune system to eliminate cancer and prevent its recurrence.

Cancer Immunology Research, the newest publication of the American Association for Cancer Research (AACR), is published.

Tech entrepreneur and philanthropist Sean Parker announced at CRI's 27th annual awards dinner that he is donating $ 1 million to CRI to support our cancer immunology research efforts.

Results were published online in Cancer Immunology Research.

«In recent years, several therapeutic medicines have been developed that spur a person's own immune system to fight cancer,» said Raul Torres, PhD, professor of immunology at National Jewish Health, and senior author on the paper, published in the October issue of Cancer Immunology Research.

In their report published in Cancer Immunology Research, a team from the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital (MGH) describes how adding AMD3100 (plerixafor)-- previously approved for the stimulation of stem cell production prior to bone marrow transplantation — to their investigational drug VIC - 008 more than doubled the animals» survival time.

A report on how the scientists created and tested what they call «ImmunoMap» appeared Dec. 20 in Cancer Immunology Research.

To investigate why checkpoint inhibitors so often stop working, Velculescu; Valsamo Anagnostou, M.D., Ph.D., instructor of oncology at the Johns Hopkins University School of Medicine; Kellie N. Smith, Ph.D., a cancer immunology research associate at the Johns Hopkins University School of Medicine; and their colleagues at the Bloomberg ~ Kimmel Institute for Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-CTLA4.

Scientists at the University of California at San Diego currently are studying MW108 in preclinical cancer immunology research.

«We've known about these cells blocking immune response for a decade, but haven't been able to shut them down for lack of an identified target,» said the paper's senior author, Larry Kwak, M.D., Ph.D., chair of Lymphoma / Myeloma and director of the Center for Cancer Immunology Research at The University of Texas MD Anderson Cancer Center.

Wolchok figures that his group's budget for cancer immunology research will double this year, rising by «several million dollars,» and likely will continue to grow, thanks to the money earned by the endowment.

He has served on National Cancer Institute (NCI) Steering Committees for Genitourinary Cancer (GUSC) and Investigational Drugs (IDSC)- Immunotherapy Task Force, and is a senior editor for Cancer Immunology Research.

Not exact matches

The increase for non-toxicology included increases in physiology (+115,100), immunology (+62,000) and parasitology (+22,000) whilst ecology -LRB--30,300), anatomy -LRB--27,000), biochemistry -LRB--11,900) and cancer research -LRB--10,200) fell.

Her work in protein research at Hunter and her grandmother's recent diagnosis of ovarian cancer sparked an interest in cancer biology and immunology, but Rezende is eager to sample other fields.

For more than a quarter of a century, Baltimore has balanced his long hours as a leading scientific administrator — founder of the seminal Whitehead Institute, president of Rockefeller University and later, for nine years, of Caltech — with groundbreaking work in cancer, immunology, and AIDS research.

Allison, chair of the immunology department at the University of Texas M.D. Anderson Cancer Center in Houston and executive director of its research center on immunotherapy, spoke with Scientific American about the future prospects and limitations of immunotherapy.

UTSW co-authors include: Co-lead author Maria Winter, a research associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver DResearch, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Diseases.

«It was kind of fun being at a medical school and known as the weird guy who worked with dogs,» says Modiano, who is now a professor of comparative oncology at the University of Minnesota College of Veterinary Medicine and the Masonic Cancer Center, where his research focuses on immunology, cancer cell biology, cancer genetics, and applications of gene thCancer Center, where his research focuses on immunology, cancer cell biology, cancer genetics, and applications of gene thcancer cell biology, cancer genetics, and applications of gene thcancer genetics, and applications of gene therapy.

Focusing on basic research for the functional regulation of innate and adaptive immunity and on translational research for cancer immunotherapies, the National Key Laboratory of Medical Immunology has been conducting innovative research and exploration, and is becoming a rising star in the international immunology Immunology has been conducting innovative research and exploration, and is becoming a rising star in the international immunology immunology community.

And at the Center for Immunology and Cancer Research, Frazer adds, «We take the belief that, at whatever level we recruit, we need to provide a sufficient startup package to ensure that their research productivity is not compromised by the move to ourResearch, Frazer adds, «We take the belief that, at whatever level we recruit, we need to provide a sufficient startup package to ensure that their research productivity is not compromised by the move to ourresearch productivity is not compromised by the move to our center.

«The cooperative research centers have fostered the growth of strong intersectoral collaborations across the field of biosciences,» observes Ian Frazer, director of the University of Queensland's Centre for Immunology and Cancer Research, and Australian of the Yeresearch centers have fostered the growth of strong intersectoral collaborations across the field of biosciences,» observes Ian Frazer, director of the University of Queensland's Centre for Immunology and Cancer Research, and Australian of the YeResearch, and Australian of the Year 2006.

«It's of note that we have more senior scientists in the Centre for Immunology and Cancer Research from overseas than from Australia.»

In his day job, at the University of Texas MD Anderson Cancer Center in Houston, Allison serves as chair of the immunology department, deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers and executive director of the immunotherapy division of the Moon Shots Program, a multidisciplinary effort tackling cancer mortCancer Center in Houston, Allison serves as chair of the immunology department, deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers and executive director of the immunotherapy division of the Moon Shots Program, a multidisciplinary effort tackling cancer mortcancer mortality.

Mandelboim is a professor and researcher at the Lautenberg Center for Immunology and Cancer Research at IMRIC — the Institute for Medical Research Israel - Canada, in the Hebrew University's Faculty of Medicine.

He is the Harder Family Chair for Cancer Research, Member and Chief, Laboratory of Molecular and Tumor Immunology, at the Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center.

«Pancreatic cancer cells are deadly because they program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU Lacancer cells are deadly because they program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU LaCancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU Langone.

This led to development of newer technology, called single cell sequencing (SCS), that has had a major impact in many areas of biology, including cancer research, neurobiology, microbiology, and immunology, and has greatly improved understanding of certain tumor characteristics in cancer.

Operating within the Hebrew University's Faculty of Medicine, IMRIC coordinates research within the departmental areas of medical neurobiology, molecular genetics and biology, immunology and cancer research.

«Our research shows that the protein GSK3 plays a crucial role in helping B cells meet the energy needs of their distinct states,» says Robert Rickert, Ph.D., director of the Tumor Microenvironment and Cancer Immunology Program at Sanford Burnham Prebys Medical Discovery Institute (SBP).

Dr. Beutler, also Professor of Immunology, holds the Raymond and Ellen Willie Distinguished Chair in Cancer Research, in Honor of Laverne and Raymond Willie, Sr..

He received the 2014 William B. Coley Award for Distinguished Research in Tumor Immunology and the 2017 Warren Alpert Foundation award for this work, which led to development of the PD - 1 pathway blockade for cancer immunotherapy.

Co-authors include: Pinar Mesci, Angela Macia, Spencer M. Moore, Leon Tejwani, Isabella R. Fernandes, Nicole A. Suarez, Sandro Montefusco, Jeremiah D. Momper, and Jair L. Siqueira - Neto, all at UC San Diego; Sergey A. Shiryaev, Antonella Pinto and Chun - Teng Huang, Sanford Burnham Prebys Medical Discovery Institute; Matthew J. Kolar and Alan Saghatelian, Salk Institute for Biological Studies; Scott C. Rosenberg, UC San Diego and Ludwig Institute for Cancer Research; Roberto H. Herai, Pontificia Universidade Catolica do Parana, Brazil; Fernanda R. Cugola, Fabriele B. Russo, and Patricia C.B. Beltrao - Braga, University of Sao Paulo, Brazil; Nicholas Sheets, and Sujan Shresta, La Jolla Institute for Allergy & Immunology; and Kevin D. Corbett, Ludwig Institute for Cancer Research.

Their research is funded by the Stand Up to Cancer Immunotherapy Dream Team grant, Prostate Cancer Foundation Challenge Grant in Immunology, the National Cancer Institute of the National Institutes of Health (CA1633793 - 01, P30 CA016672) and the Cancer Prevention and Research Institute oresearch is funded by the Stand Up to Cancer Immunotherapy Dream Team grant, Prostate Cancer Foundation Challenge Grant in Immunology, the National Cancer Institute of the National Institutes of Health (CA1633793 - 01, P30 CA016672) and the Cancer Prevention and Research Institute oResearch Institute of Texas.

It was based on the research of Jim Allison, Ph.D., chair of Immunology, executive director of the immunotherapy platform and director of the Parker Institute for Cancer Immunotherapy at MD Anderson.

This new approach «represents an important advancement,» said Felicia Goodrum Sterling, the director of the graduate program in immunology at the University of Arizona Cancer Center, who was not involved in the research.

«Therapies for metastatic prostate cancer are urgently needed,» said Dr. Owen Witte, founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, university professor of microbiology, immunology and molecular genetics at the UCLA David Geffen School of Medicine, and a senior author of the paper.

PHILADELPHIA --(July 11, 2017)-- Researchers at The Wistar Institute, an international leader in biomedical research in the fields of cancer, immunology and infectious diseases, with collaborators at Indiana University Melvin and Bren Simon Cancer Center and Syndax Pharmaceuticals, Inc., (Nasdaq: SNDX) announce the results of a preclinical study demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (Mcancer, immunology and infectious diseases, with collaborators at Indiana University Melvin and Bren Simon Cancer Center and Syndax Pharmaceuticals, Inc., (Nasdaq: SNDX) announce the results of a preclinical study demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (MCancer Center and Syndax Pharmaceuticals, Inc., (Nasdaq: SNDX) announce the results of a preclinical study demonstrating that entinostat, Syndax's oral, Class - I histone deacetylase inhibitor, enhances the antitumor effect of PD - 1 (programmed death receptor - 1) blockade through the inhibition of myeloid derived suppressor cells (MDSCs).

An international research team led by Université de Montréal medical professor Christopher Rudd, director of research in immunology and cell therapy at Maisonneuve - Rosemont Hospital Research Centre, has identified a key new mechanism that regulates the ability of T - cells of the immune system to react against foreign antigens andresearch team led by Université de Montréal medical professor Christopher Rudd, director of research in immunology and cell therapy at Maisonneuve - Rosemont Hospital Research Centre, has identified a key new mechanism that regulates the ability of T - cells of the immune system to react against foreign antigens andresearch in immunology and cell therapy at Maisonneuve - Rosemont Hospital Research Centre, has identified a key new mechanism that regulates the ability of T - cells of the immune system to react against foreign antigens andResearch Centre, has identified a key new mechanism that regulates the ability of T - cells of the immune system to react against foreign antigens and cancer.

An initial research concept (succinct description of the proposed research, description of the relevance of the proposed research to cancer immunology, description of how your proposed project bridges laboratory and clinical discovery), not to exceed 3 pages.

Scientists from the RIKEN Research Centre for Allergy and Immunology in Yokohama, Japan, explained in the journal Cell Stem Cell (January 2013 issue) how they managed to make cancer - specific immune system cells from iPSCs (induced pluripotent stem cells) to destroy cancer cells.

Dr. Kunle Odunsi is the deputy director of the Roswell Park Cancer Institute, where he also serves as the chair of the Department of Gynecologic Oncology, the executive director of the Center for Immunotherapy, and the co-Leader of the Tumor Immunology and Immunotherapy research program.

In addition to Amgen's work to improve cancer patient treatment through science - based innovation, CRI will also recognize the company's commitment to the broader scientific and patient communities, both through its support of CRI's Cancer Immunotherapy Month education and awareness initiative, and for its support of the CRI - CIMT - EATI - AACR International Cancer Immunotherapy Conference, a joint program of four cancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy rescancer patient treatment through science - based innovation, CRI will also recognize the company's commitment to the broader scientific and patient communities, both through its support of CRI's Cancer Immunotherapy Month education and awareness initiative, and for its support of the CRI - CIMT - EATI - AACR International Cancer Immunotherapy Conference, a joint program of four cancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy resCancer Immunotherapy Month education and awareness initiative, and for its support of the CRI - CIMT - EATI - AACR International Cancer Immunotherapy Conference, a joint program of four cancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy resCancer Immunotherapy Conference, a joint program of four cancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy rescancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy rescancer immunology and immunotherapy research.

Cancer Research Institute inaugurates its Investigator Award Program for junior faculty members working in immunology and tumor immunology.